Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
204
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Metabonomic Analysis of Metabolites Produced by Escherichia coli in Patients With and Without Sepsis

Yangyanqiu Wang1 Department of General Intensive Care Unit, Huzhou Central Hospital, Huzhou Hospital Affiliated to Zhejiang University School of Medicine, Huzhou, People’s Republic of ChinaView further author information
,
Yin Jin2 Department of Clinical Laboratory, Huzhou Central Hospital, Huzhou Hospital Affiliated to Zhejiang University School of Medicine, Huzhou, People’s Republic of ChinaView further author information
,
Xiaowei Ji1 Department of General Intensive Care Unit, Huzhou Central Hospital, Huzhou Hospital Affiliated to Zhejiang University School of Medicine, Huzhou, People’s Republic of ChinaView further author information
,
Man Huang3 Department of General Intensive Care Unit, The Second Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of ChinaView further author information
&
Bo Xie1 Department of General Intensive Care Unit, Huzhou Central Hospital, Huzhou Hospital Affiliated to Zhejiang University School of Medicine, Huzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 7339-7350 | Received 06 Sep 2022, Accepted 29 Nov 2022, Published online: 13 Dec 2022

References

  • Fernando SM, Rochwerg B, Seely AJE. Clinical implications of the third international consensus definitions for sepsis and septic shock (Sepsis-3). CMAJ. 2018;190(36):E1058–E1059. doi:10.1503/cmaj.170149
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
  • Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–1562. doi:10.1007/s00134-020-06151-x
  • Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–2329. doi:10.1001/jama.2009.1754
  • Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–353. doi:10.1097/01.CCM.0000194725.48928.3A
  • Karlsson S, Varpula M, Ruokonen E, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med. 2007;33:435–443. doi:10.1007/s00134-006-0504-z
  • Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2:380–386. doi:10.1016/S2213-2600(14)70061-X
  • Vincent JL, Lefrant JY, Kotfis K, et al. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP). Intensive Care Med. 2018;44(3):337–344. doi:10.1007/s00134-017-5043-2
  • Zekavat SM, Lin SH, Bick AG, et al. Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection. Nat Med. 2021;27(6):1012–1024. doi:10.1038/s41591-021-01371-0
  • Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1991;115(6):457–469. doi:10.7326/0003-4819-115-6-457
  • van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407–420. doi:10.1038/nri.2017.36
  • Deng W, Bai Y, Deng F, et al. Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis. Nature. 2022;602(7897):496–502. doi:10.1038/s41586-021-04384-4
  • Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–670. doi:10.1681/ASN.2013080905
  • Oda M, Terao Y, Sakurai J, Nagahama M. Membrane-binding mechanism of clostridium perfringens alpha-toxin. Toxins. 2015;7(12):5268–5275. doi:10.3390/toxins7124880
  • González-Domínguez R, Sayago A, Fernández-Recamales Á. Direct infusion mass spectrometry for metabolomic phenotyping of diseases. Bioanalysis. 2017;9(1):131–148. doi:10.4155/bio-2016-0202
  • Izquierdo-García JL, Nin N, Ruíz-Cabello J, et al. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med. 2011;37(12):2023–2032. doi:10.1007/s00134-011-2359-1
  • Parent BA, Seaton M, Sood RF, et al. Use of metabolomics to trend recovery and therapy after injury in critically ill trauma patients. JAMA Surg. 2016;151(7):e160853. doi:10.1001/jamasurg.2016.0853
  • Mickiewicz B, Vogel HJ, Wong HR, et al. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med. 2013;187(9):967–976. doi:10.1164/rccm.201209-1726OC
  • Jaurila H, Koivukangas V, Koskela M, et al. 1H NMR based metabolomics in human sepsis and healthy serum. Metabolites. 2020;10(2):70. doi:10.3390/metabo10020070
  • Liu Z, Triba MN, Amathieu R, et al. Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors. Crit Care. 2019;23(1):169. doi:10.1186/s13054-019-2456-z
  • Silas Y, Singer E, Das K, et al. A combination of Class-I fumarases and metabolites (α-ketoglutarate and fumarate) signal the DNA damage response in Escherichia coli. Proc Natl Acad Sci U S A. 2021;118(23):e2026595118. doi:10.1073/pnas.2026595118
  • Xue M, Kim CS, Healy AR, et al. Structure elucidation of colibactin and its DNA cross-links. Science. 2019;365(6457):eaax2685. doi:10.1126/science.aax2685

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.